Tag: cbd glaucoma

Can Glaucoma Be Treated With CBD And THC When They Are Included In CBD?


According to research, glaucoma is one of the most common eye conditions on a worldwide scale with figures showing that roughly 60 million people go through the condition in their lives. The USA presents using a statistic of more than three million people living with glaucoma and when this is untreated it can result in irreversible blindness.
Since 1980, surgical procedures and treatments have significantly enhanced the statistics of cancer patients. The processes have effectively treated the optical nerve damage brought on by glaucoma and the probability of developing blindness was decreased by roughly 50%. Nonetheless, while progressing therapies have reduced the probability of blindness in glaucoma patients, the amount of effective topical medication continues to be restricted. As such, medical marijuana has been stated as a successful remedy with many people choosing this alternative – but if they be doing this?
Due to the improvement of glaucoma treatments over recent years, an individual has to question whether or not the benefits of medical marijuana outweigh the possible dangers or side effects? Furthermore, the role of the human body’s endocannabinoid system in disorder ought to be considered when determining if development of cannabinoid-based drugs are beneficial for treating this illness cbd glaucoma.
• What Causes Glaucoma?
Medical studies have found that glaucoma has a strong connection to different neurodegenerative conditions, such as Alzheimer’s disease, and is therefore being regarded as a neurodegenerative disease. The research suggests that one of four patients with Alzheimer’s disease will present with a diagnosis of glaucoma and, in reality, glaucoma seemed to be a predictor of Alzheimer’s. The exact cause of the eye illness, however, continues to be a mystery and elude the health community.
Due to intraocular pressure influencing the onset and progression of glaucoma, ophthalmologists have started to prescribe therapies that target this intraocular pressure, shortened to IOP. Evidence has shown that the sole technique for preventing irreversible blindness or vision loss is the decrease of IOP levels using different therapies. The type of treatment chosen is typically dependent on the severity and the progression of this eye conditionnonetheless, ophthalmologists will more often than not treat glaucoma with prescription drugs. A severe case would potentially necessitate operation.
• Is CBD A Viable Treatment For Glaucoma?
Studies in the 1970s suggest that cannabinoids present with properties that can reduce glaucoma-related symptoms because of their ability for lowering the IOP levels in the patient. Furthermore, the cannabinoids presented with neuroprotective actions. Back in 1971, the initial research of CBD as therapy for glaucoma found that ingestion of this substance decreased the patient’s IOP amounts by 25-30 percent.
Regardless of the medical findings in the study by the 1970s, it’s rare that an ophthalmologist will use medical marijuana in patients experiencing premature to mid-stage glaucoma. The primary issue many ophthalmologists have with the use of medical CBD is the possible side effects and the way smoking CBD can outweigh the brief term benefits of this therapy. For instance, smoking CBD could lead to unstable intraocular pressure levels, thus increasing the chance of irreversible blindness from the individual.
Another point of concern that many ophthalmologists have is that the curative effects of medical marijuana are short term for glaucoma patients; therefore, the individual would have to eat CBD on a regular basis – potentially every three or four hours. Medical professionals have promised that glaucoma requires therapy 24 hours every day and patients would need to consume medical CBD approximately six to eight times in 1 day to be suitably treated for their condition. A frequency in this degree can be difficult to keep and, due to the total amount of intake, can increase the probability of developing a CBD addiction.
When the patient is undergoing a late stage glaucoma condition, it is often found that ophthalmologists are more inclined to decide on medical marijuana as a form of therapy. This is because of the fact that treatment at the late stage of glaucoma focuses more on relieving the related symptoms of this illness rather than targeting the illness itself. Based on Andrew Bainnson, the medical community has been aware of the effectiveness of medical marijuana in treating nausea and pain; however, not glaucoma. Obviously, there are patients in the end stage of nausea and pain which may benefit from this treatment but not from the perspective of glaucoma.
• Are CBD-Based Remedies Beneficial As Future Glaucoma Treatments?
One of the most critical physiological systems in the human body is its internal cannabinoid system, also referred to as the endocannabinoid system. Nearly all facets of the body’s health, such as immune system reaction, inflammation, pain modulation and neuroprotection are all dependent on the abilities of the endocannabinoid system. As such, most medical researchers feel that the evolution and application of cannabinoid-based treatments can be quite beneficial in treatment and possibly preventing conditions such as glaucoma.
The cannabinoid receptors within the body are prominent in ocular cells responsible for the regulation of intraocular pressure. Future medical investigation is currently working towards the development of cannabinoid-based drugs to target these problems. This kind of medication will be tremendously beneficial in that it will treat two separate issues: reducing the intraocular pressure and security of bronchial cells.
Current studies have found that two cannabinoid agonists (WIN 55212-2 and anandamid) and several different cannabinoids, such as CBG and CBD, can be helpful when creating treatments for glaucoma.
Unfortunately, problems that are not unique to medical marijuana are still exist. An oral preparation and use of CBD is not valuable since the bioavailability is poor with absorption being inconsistent. Furthermore, inhalation of CBD isn’t successful as the effects are not long-lasting.